ClinVar Miner

Variants studied for bladder transitional cell carcinoma

Included ClinVar conditions (1):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
0 276 0 0 0 276

Gene and significance breakdown #

Total genes and gene combinations: 27
Download table as spreadsheet
Gene or gene combination likely pathogenic total
TP53 119 119
PIK3CA 32 32
CTNNB1, LOC126806658 21 21
BRAF 11 11
HRAS, LRRC56 11 11
ERBB2 10 10
FBXW7 10 10
NFE2L2 8 8
NRAS 8 8
CDKN2A 5 5
ERBB3 5 5
IDH1 5 5
CREBBP 4 4
FGFR3 3 3
MAP2K1 3 3
SF3B1 3 3
CNOT9 2 2
EP300 2 2
FGFR1 2 2
MTOR 2 2
RHEB 2 2
RXRA 2 2
U2AF1 2 2
AKT1 1 1
KRAS 1 1
MAPK1 1 1
PTEN 1 1

Submitter and significance breakdown #

Total submitters: 1
Download table as spreadsheet
Submitter likely pathogenic total
Database of Curated Mutations (DoCM) 276 276

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.